India's Zydus Life posts Q2 profit rise on steady US demand November 12, 2024 Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by ...

India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.